{"title":"妊娠第三孕期发现急性髓细胞白血病","authors":"","doi":"10.54289/jcrmh2400148","DOIUrl":null,"url":null,"abstract":"Acute leukemia (AL) rarely occurs during pregnancy. Its incidence is estimated at 1/100 000 pregnancies. In 2/3 of the cases, it is acute myeloblastic leukemia (AML). The dilemma is between chemotherapy which should not be delayed for a better therapeutic prognosis and a foetus at risk of malformation or morbidity and mortality by induced prematurity. We report the observation of a 25-year-old patient in whom we diagnosed AML occurring during a pregnancy at 35 weeks of amenorrhea, and who benefited from obstetrical management then chemotherapy.","PeriodicalId":484263,"journal":{"name":"Journal of Case Reports and Medical History","volume":" 24","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acute Myeloblastic Leukemia Discovered in the 3rd Trimester of Pregnancy\",\"authors\":\"\",\"doi\":\"10.54289/jcrmh2400148\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Acute leukemia (AL) rarely occurs during pregnancy. Its incidence is estimated at 1/100 000 pregnancies. In 2/3 of the cases, it is acute myeloblastic leukemia (AML). The dilemma is between chemotherapy which should not be delayed for a better therapeutic prognosis and a foetus at risk of malformation or morbidity and mortality by induced prematurity. We report the observation of a 25-year-old patient in whom we diagnosed AML occurring during a pregnancy at 35 weeks of amenorrhea, and who benefited from obstetrical management then chemotherapy.\",\"PeriodicalId\":484263,\"journal\":{\"name\":\"Journal of Case Reports and Medical History\",\"volume\":\" 24\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Case Reports and Medical History\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.54289/jcrmh2400148\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Case Reports and Medical History","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.54289/jcrmh2400148","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Acute Myeloblastic Leukemia Discovered in the 3rd Trimester of Pregnancy
Acute leukemia (AL) rarely occurs during pregnancy. Its incidence is estimated at 1/100 000 pregnancies. In 2/3 of the cases, it is acute myeloblastic leukemia (AML). The dilemma is between chemotherapy which should not be delayed for a better therapeutic prognosis and a foetus at risk of malformation or morbidity and mortality by induced prematurity. We report the observation of a 25-year-old patient in whom we diagnosed AML occurring during a pregnancy at 35 weeks of amenorrhea, and who benefited from obstetrical management then chemotherapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
